Flash FinanceUS
Pre-market S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI filing briefs · archive

8-K filings in May 2023, explained

17 material Form 8-K filings that 16 companies we cover made with the SEC in May 2023, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

1 of 17 briefs matches

newest first · times in ET
SCNIScinai Immunotherapeutics Ltd. May 4, 4:30 PM ET

Scinai receives Nasdaq deficiency notice over $2.5 million stockholders' equity rule

Negative legal/regulatory Written later 3.01

BiondVax Pharmaceuticals Ltd., which the filing identifies as the registrant for Scinai (SCNI), received a Nasdaq letter on May 1, 2023 saying it does not meet the $2,500,000 minimum stockholders' equity requirement for the Nasdaq Capital Market. The company reported a stockholders' deficit of $1,760,000 in its 2022 annual report, and the notice has no immediate effect on its ADSs, which continue to trade as BVXV.

  • Nasdaq letter dated May 1, 2023 cites the $2,500,000 minimum stockholders' equity requirement under Listing Rule 5550(b)(1).
  • Stockholders' deficit of $1,760,000 reported in the 10-K for the year ended December 31, 2022, filed April 17, 2023.
  • Compliance plan due to Nasdaq by June 15, 2023; if accepted, Nasdaq may grant 180 calendar days to regain compliance.
  • The company does not currently meet Nasdaq's alternative standards for market value of listed securities or net income from continuing operations.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.